Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic.

Patel, Rachna; Czuprynska, Julia; Roberts, Lara N; Vadher, Bipin; Rea, Catherine; Patel, Raj; Gee, Emma; Saul, Gabrielle; Coles, Evelyn; Brown, Alison; Byrne, Rosalind; Speed, Vicky; Patel, Jignesh P; Arya, Roopen

Patel, Rachna; Czuprynska, Julia; Roberts, Lara N; Vadher, Bipin; Rea, Catherine; Patel, Raj; Gee, Emma; Saul, Gabrielle; Coles, Evelyn; Brown, Alison; Byrne, Rosalind; Speed, Vicky; Patel, Jignesh P; Arya, Roopen.

Patel R; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland. Electronic address: rachnapatel1@nhs.net.
Czuprynska J; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Roberts LN; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Vadher B; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Rea C; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Patel R; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Gee E; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Saul G; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Coles E; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Brown A; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Byrne R; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Speed V; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Patel JP; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.
Arya R; Department of Haematological Medicine, Kings College Hospital, United Kingdom of Great Britain and Northern Ireland.

Thromb Res ; 197: 192-194, 2021 01.

Article in English | MEDLINE | ID: covidwho-912641

Subject(s)

Anticoagulants/therapeutic use; COVID-19/complications; Drug Substitution/methods; Pandemics; Pyridines/therapeutic use; Rivaroxaban/therapeutic use; SARS-CoV-2; Thiazoles/therapeutic use; Thrombophilia/drug therapy; Warfarin/therapeutic use; Administration, Oral; Anticoagulants/adverse effects; COVID-19/blood; COVID-19/epidemiology; COVID-19/prevention & control; Counseling; Drug Monitoring; Hospitals, University/organization & administration; Hospitals, University/statistics & numerical data; Humans; Informed Consent; London/epidemiology; Patient Acceptance of Health Care; Patient Education as Topic; Pyridines/adverse effects; Quarantine; Rivaroxaban/adverse effects; Telemedicine; Tertiary Care Centers/organization & administration; Tertiary Care Centers/statistics & numerical data; Thiazoles/adverse effects; Thrombophilia/etiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pyridines / Thiazoles / Warfarin / Thrombophilia / Drug Substitution / Pandemics / Rivaroxaban / SARS-CoV-2 / COVID-19 / Anticoagulants Type of study: Observational study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Thromb Res Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google